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ABSTRACT Phosphorylation of GTP-binding-regulatory
(G)-protein-coupled receptors by specific G-protein-coupled
receptor kinases (GRKs) is a major mechanism responsible for
agonist-mediated desensitization of signal transduction pro-
cesses. However, to date, studies of the specificity of these
enzymes have been hampered by the difficulty of preparing the
purified and reconstituted receptor preparations required as
substrates. Here we describe an approach that obviates this
problem by utilizing highly purified membrane preparations
from Sf9 and 293 cells overexpressing G-protein-coupled re-
ceptors. We use this technique to demonstrate specificity of
several GRKs with respect to both receptor substrates and the
enhancing effects of G-protein (,y subunits on phosphoryla-
tion. Enriched membrane preparations of the 132- and a2-C2-
adrenergic receptors (ARs, where a2-C2-AR refers to the AR
whose gene is located on human chromosome 2) prepared by
sucrose density gradient centrifugation from Sf9 or 293 cells
contain the receptor at 100-300 pmol/mg of protein and serve
as efficient substrates for agonist-dependent phosphorylation
by (AR kinase 1 (GRK2), 3-AR kinase 2 (GRK3), or GRK5.
Stoichiometries of agonist-mediated phosphorylation of the
receptors by GRK2 (.*AR kinase 1), in the absence and
presence of Ga3y, are 1 and 3 mol/mol, respectively. The rate
of phosphorylation of the membrane receptors is 3 times faster
than that of purified and reconstituted receptors. While phos-
phorylation of the P2-AR by GRK2, -3, and -5 is similar, the
activity of GRK2 and -3 is enhanced by G13,y whereas that of
GRK5 is not. In contrast, whereas GRK2 and -3 efficiently
phosphorylate a2-C2-AR, GRK5 is quite weak. The availability
of a simple direct phosphorylation assay applicable to any
cloned G-protein-coupled receptor should greatly facilitate
elucidation of the mechanisms of regulation of these receptors
by the expanding family of GRKs.
Signal transduction through GTP-binding-regulatory (G)-
protein-coupled receptors is a dynamically regulated pro-
cess. Classically, the intensity of the signal wanes over time
despite the presence ofthe agonist. This phenomenon, which
is referred to as agonist-mediated desensitization, involves as
a key mechanism, the phosphorylation of the receptor by
specific kinases (1). Two classes of these enzymes partici-
pate. The first is the second messenger-regulated kinases,
cAMP-dependent protein kinase A and protein kinase C. The
second is a recently appreciated kinase subfamily known as
the G-protein-coupled receptor kinases (GRKs) (for review,
see ref. 2). Phosphorylation ofreceptors by GRKs appears to
trigger the binding of another protein (arrestin or ,3arrestin)
thereby uncoupling the receptors from activation of the
G-protein/effector systems (2, 3). To date six members of the
GRK family have been cloned (GRK1-GRK6) (4-11) includ-
ing rhodopsin kinase (GRK1) (4) and two forms of f3-adren-
ergic receptor kinase (fARK; 3ARK1 or GRK2 and ,3ARK2
or GRK3) (5-7). IT-1l (GRK4) was identified by the sequenc-
ing of an open reading frame in the vicinity of the Huntington
disease locus (8); GRK5 is a recently discovered widely
distributed enzyme of unknown function (9, 10); and GRK6
was obtained by low-stringency screening ofhuman heart and
lymphocyte cDNA libraries (11, 12). Phosphorylation of
receptors by GRKs appears to be strictly dependent on the
receptor being in its agonist-activated state. For the (2-AR,
phosphorylation by GRK2 and -3 (13) but not by GRK5 (10)
is enhanced by G-protein fry subunits, which bind to the
cytosolic kinases and target them to the membrane bound
receptor (13).
Phosphorylation of G-protein-coupled receptors by GRKs
is an important mechanism by which the intensity and
duration of agonist stimulation are regulated. These mecha-
nisms regulate light perception in mammals and flies as well
as the biological activity of hormones and neurotransmitters
in various mammalian systems (1, 2, 14). Recent evidence
suggests that these mechanisms may also be important in
olfactory perception (15, 16). However, direct biochemical
evidence for the phosphorylation of G-protein-coupled re-
ceptors exists for only a handful of receptors including
rhodopsin, A32-AR, a2-Clo-AR (the AR whose gene is located
on human chromosome 10), the muscarinic (M2) receptors,
and substance P receptors (17-21). Moreover, almost nothing
is known of the receptor specificity of the GRKs and the
determinants that govern specific receptor-kinase interac-
tions. This relative lack of information is largely due to the
lack of a simple reliable biochemical assay for receptor
phosphorylation and the difficulties in preparing suitable
quantities of purified reconstituted G-protein-coupled recep-
tors for such studies. In the past, GRK-catalyzed phosphor-
ylation of G-protein-coupled receptors had to be accom-
plished either in whole cells with subsequent purification of
receptor or with purified reconstituted receptors. In this
report, we describe the development of a direct biochemical
assay for receptor phosphorylation in which purified mem-
branes overexpressing the receptors are used as substrates.
We utilize this approach to demonstrate specificity for three
GRKs both with respect to receptor substrates and the
enhancement of activity by G-protein 8ry subunits.
EXPERIMENTAL PROCEDURES
Expression of P2-AR and a2-C2-AR. Recombinant human
A-AR and a2-C2-AR (the AR whose gene is located on human
Abbreviations: AR, adrenergic receptor; BARK, 3-adrenergic re-
ceptor kinase; G protein, GTP binding regulatory protein; GRK,
G-protein-coupled receptor kinase.
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chromosome 2) were expressed in Spodoptera frugiperda
(Sf9) cells using baculovirus expression technology as rec-
ommended by PharMingen. Human 32-AR was also tran-
siently transfected in human embryonic kidney (293) cells by
a modified calcium phosphate method (22). Expression levels
of IA-AR and a2-C2-AR were determined by radioligand
binding using [1251]iodocyanopindolol (NEN) and [3Hlrau-
wolscine (NEN), respectively, as described (23, 24).
Sucrose Gradient Centrfuton. Cells were harvested 48 h
after infection (Sf9) or 60 h after transfection (293), washed
in ice-cold phosphate-buffered saline, and lysed in a hypo-
tonic buffer (20 mM Tris HCI/2 mM EDTA, pH 7.4) con-
taiing leupeptin (10 pg/ml), benzamidine (10 pg/ml), apro-
tinin (10 pg/ml), pepstatin A (5 pg/ml), and 0.2 mM phenyl-
methylsulfonyl fluoride (buffer A). Crude membranes were
collected by centrifugation at 40,000 x g for 30 min (40C),
resuspended, and homogenized with a Polytron (Brinkman
Instruments) on ice for 15 s in buffer A. Crude membranes
were fractionated on a sucrose gradient as described (25).
Briefly, crude membranes (2-15 mg of proteins) were layered
on top of stepwise gradient consisting of 3.5 ml of 60%o
(wt/vol) sucrose and 4 ml of 35% sucrose prepared in buffer
A and centrifuged at 115,000 x g for 90 min (4°C). At the end
of centrifugation, the 0-35% sucrose interface containing a
light membrane fraction was collected, washed in buffer A
containing 250 mM NaCl, and centrifuged at 40,000 x g for
30 min (4C). Pellets were resuspended once again in buffer
A containing 250 mM NaCl and centrifuged at 40,000 x g for
30 min (4°C). Finally, membrane pellets were washed in
buffer A alone, centrifuged, resuspended in buffer A, and
stored at -70°C.
Receptor Phosphorylatlon by GRKs. Recombinant GRK2(,BARK1), GRK3 (,BARK2), and GRK5 expressed in Sf9 cells
and G-protein fry subunits from bovine brain were purified to
near homogeneity (>90%o) as reported (5, 7, 10, 26). Phos-
phorylation of purified and reconstituted (32-AR (>75% pu-
rity) (27, 28), A32-AR membranes, and a2-C2-AR membranes
by purified GRK2, GRK3, or GRK5 was performed as
described (5, 7, 10) for purified receptor preparations.
Briefly, the reaction mixtures (25 Al) consisted of -1 pmol of
receptor, 10-60 nM kinase, ±300-600 nM G-protein fry
subunits, and ±100 ,uM (-)-isoproterenol (for (2-AR) or
±100 ,uM epinephrine (for a2-C2-AR) in 20mM TrisHCl, pH
8.0/2 mM EDTA/10 mM MgCl2/1 mM dithiothreitol. The
reactions were started by adding 100 puM ATP (3000-6000
cpm/pmol; NEN) and incubated at 300C. At the times
indicated, the phosphorylation was stopped with 25 pl of
SDS-sample-loading buffer [8% (wt/vol) SDS/25 mM
Tris*HCl, pH 6.5/10% (vol/vol) glycerol/1% mercaptoetha-
nol/0.005% bromophenol blue] and electrophoresed (SDS/
PAGE) on SDS/101% polyacrylamide gels. Phosphorylation
stoichiometries of receptor were determined either by excis-
ing the receptor bands and measuring radioactivity or by
using a Phospholmager (Molecular Dynamics) as described
(29).
RESULTS
Membrane Fractionation and in Vitro Phosphorylatlon of
(32-AR and a2-C2-AR by GRK2. Infection of Sf9 cells with
/32-AR or a2-C2-AR or transfection of 293 cells with (h-AR led
to the expression of functional receptors at a level of -15
pmol/mg of crude membrane protein. Further purification of
these crude membrane preparations on a discontinuous su-
crose gradient by centrifugation followed by a high salt wash
yielded an "20-fold enrichment of receptor specific binding
activity for Sf9 cells and a 7- to 10-fold enrichment for 293
cells. Thus, final specific activity of receptor binding in the
purified membrane preparations was 100-300 pmol/mg of
protein.
As shown in Fig. 1, these purified membrane preparations
could be used in an in vitro assay to phosphorylate G-protein-
coupled receptors with GRKs. The (3z-ARs either from Sf9
membranes (Fig. 1B) or 293 membranes (Fig. 1C) could be
phosphorylated by BARK1 (GRK2) in an agonist-dependent
fashion and appeared as a major band on SDS/PAGE gels
centered at "'SO kDa. For comparison, Fig. 1A shows the
pattern of phosphorylation obtained with 32-AR purified
from Sf9 cells and reconstituted into phospholipid vesicles.
Furthermore, GRK2-catalyzed phosphorylation of fA-AR in
membranes was significantly enhanced by G-protein fBy
subunits, a phenomenon previously demonstrated in the
phosphorylation of the purified and reconstituted C-AR.
Under the same conditions, a2-C2-AR in purified Sf9 mem-
branes could also be phosphorylated by GRK2 in an agonist-
dependent fashion that was enhanced by G-protein fBy sub-
units (Fig. iD). For both 32-AR and a2-C2-AR either in Sf9
membranes or 293 membranes, the stoichiometry ofreceptor
phosphorylation was ='1 mol of phosphate per mol of recep-
tor in the presence ofmaximal concentrations of agonist and
reached "3 mol of Pi per mol of receptor in the presence of
G-protein fy subunits. As documented earlier (13), using
purified and reconstituted P2-AR, the stoichiometry of phos-
phorylation is 1-2 mol of Pi per mol of receptor in the
presence of agonist alone and rises to 7-10 mol of Pi per mol
of receptor upon addition of agonist and G-protein fBy sub-
units. The phosphorylated band at "'80 kDa, which is appar-
ent in Fig. 1, presumably represents autophosphorylation of
GRK2 and it, too, appears to be enhanced in the presence of
,13'y subunits.
Time Course of GRK2 Phosphorylation of I2-AR. The
results shown in Fig. 2 compare the time courses of GRK2-
mediated phosphorylation of the 2-AR in membranes with
that of the purified reconstituted receptors. The phosphory-
lation rate for the membranes is "3 times faster than that of
the purified reconstituted receptors (t1/2, --5 min vs. ='15
min).
Specficty of Phosphorylation of Membrane-Bound AR by
Various GRKs. GRK2, -3, and -5 effectively phosphorylated
the (2-AR in Sf9 membranes in the presence of the agonist
isoproterenol (100 ILM) (Fig. 3). Interestingly, while GRK2
and -3 phosphorylate A-AR to "'1 mol of Pi per mol of
receptors, the extent of phosphorylation with GRK5 in the
presence of agonist is twice as high (-z2 mol of Pi per mol of
receptor) (Fig. 3). However, the GRK2 or GRK3 phosphor-
ylation ofC-AR membranes was greatly enhanced by G-pro-
tein fry subunits, whereas the GRK5 phosphorylation was
independent of G,8y subunits. Thus, in the presence of GIry
both GRK2 and GRK3 are more effective than GRK5 in
phosphorylating membrane-bound (h-AR, in agreement with
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FIG. 1. Phosphorylation of P-AR and a2-C2-AR by GRK2.
p2-AR purified and reconstituted into phospholipid vesicles (A),
P2-AR in membranes from 519 cells (B), P2-AR in membranes from
293 cells (C), and a2-C2-AR in membranes from 519 cells (D) were
phosphorylated by GRK2 at 30"C for 20 min in the absence (lanes 1)
or in the presence ofisoproterenol (100 pM) for P2-AR or epinephrine
(100 pM) for a2-C2-AR (lanes 2 and 3) or plus G-protein (By subunits
(lanes 3). The experiments were replicated four to seven times with
similar results.
3634 Biochemistry: Pei et al.
Proc. Natl. Acad. Sci. USA 91 (1994) 3635
A
P2-AR membranes p2-AR reconstituted












FIG. 2. Time course of GRK2 phosphorylation of p2-AR in
membranes and reconstituted phospholipid vesicles. h82-AR in mem-
branes and purified P2-AR reconstituted into phospholipid vesicles
were phosphorylated at 30°C for the times indicated in minutes in the
presence of isoproterenol (iso, 100 IAM). A 60-min point without
isoproterenol is also shown as 60. The stoichiometries of Pi incor-
poration in autoradiograms ofSDS/PAGE gels (A) were quantitated
and plotted in B. The experiments were repeated three times with
similar results.
earlier results obtained with purified reconstituted A32-AR
(10).
As shown in Fig. 4, the a2-C2-AR in membranes was
comparable to the Ah-AR in serving as a substrate for either
GRK2 or GRK3. In contrast, however, the extent of phos-
phorylation ofthe a2-C2-AR by GRK5 was only =20% of that
ofthe (32-AR and phosphorylation was independent of G-pro-
tein 83'y subunits. In other words, GRK5 was a much less
effective kinase for modifying a2-C2-AR than either GRK2 or
GRK3, especially in the presence ofG-protein Pfy subunits (6-
to 8-fold difference). These results clearly demonstrate that
biological specificity does exist in GRK phosphorylation of
G-protein-coupled receptors.
DISCUSSION
In this paper, we report the development of an in vitro
biochemical approach that facilitates the assessment of the
properties of various GRKs in terms of their abilities to
phosphorylate G-protein-coupled receptors and to be regu-
lated by G-protein fry subunits. Specifically, we show that
GRK2, -3, and -5 effectively phosphorylate the ,32-AR in an
agonist-dependent fashion. G-protein 8ry subunits, which
have been shown to enhance receptor phosphorylation in
purified reconstituted 2-AR preparations (13), enhance
phosphorylation in the in vitro membrane assay also. GRK2
and -3 are also efficient enzymes for a2-C2-AR phosphory-
lation in contrast to GRK5, which is markedly less effective
at phosphorylating the a2-C2-AR. In addition, in contrast to
GRK2 and -3, no effects of fry subunits are observed on the
activity of GRK5 for phosphorylating either the f2- or a2-
C2-AR.
The hallmark ofGRKs is that they can only phosphorylate
receptors in their agonist-activated state and this conforma-
tion requires the receptor to be embedded in its native
environment of a bilayer. In the past, the only G-protein-
coupled receptor system that has been amenable to direct
biochemical studies in plasma membranes has been the visual
0
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FIG. 3. Comparison of P2-AR phosphorylation by GRKs. p2-AR
in membranes from Sf9 cells was phosphorylated in the presence of
isoproterenol (100 ELM) at 30TC for 20 min by GRK2, GRK3, or
GRK5, with (stippled bars) or without (open bars) G-protein 8y
subunits. The maximum stoichiometries of Pi incorporation were
determined from at least three experiments. Error bars represent
SEM.
transduction system in which rod outer segments containing
in excess of 80% rhodopsin are used. For other G-protein-
coupled receptors, however, despite repeated attempts, over
several years, it has never been possible to phosphorylate
receptors with GRKs by using plasma membrane prepara-
tions (J. L. Benovic, M. M. Kwatra, M.G.C., and R.J.L.,
unpublished observations). Previous experiments with ARs
and GRKs have been performed in whole cells with subse-
quent receptor purification or with purified receptors recon-
stituted in phospholipid vesicles (1). This has severely limited
exploration of these mechanisms in detail. The approach
described here, which uses an enriched membrane prepara-
tion from insect or mammalian cells expressing high levels of
receptors should be readily applicable to any G-protein-
coupled receptor that can be expressed in such heterologous
systems. This development thus represents a major advance
to elucidate these mechanisms.
Several factors may contribute to the phosphorylation of
G-protein-coupled receptors by GRKs in the enriched mem-
brane preparations: (i) the 10- to 20-fold enrichment in
specific activity of receptors might be sufficient to provide
enough receptor in a single assay to observe the phosphor-
ylated protein, (ii) a reduction of background phosphoryla-
tion due to the removal of other kinases by purification or salt
wash of membranes may enhance the detection of GRK-
phosphorylated receptors, and (iii) the possible removal of
putative GRK inhibitors present in crude preparations may




FIG. 4. Comparison of a2-C2-AR phosphorylation by GRKs.
a2-C2-AR in membranes from Sf9 cell membranes was phosphory-
lated in the presence of epinephrine (100 zM) at 30°C for 20 min by
GRK2, GRK3, or GRK5, with (stippled bars) or without (open bars)
G-protein ,fy subunits. The maximum stoichiometries of Pi incorpo-
ration were determined from at least three experiments.
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this study, receptor phosphorylation can be observed in
purified membranes from more than one cell type, Sf9 and
293 cells. However, the success of this approach is likely to
depend on more complex factors than simply overexpression
and membrane enrichment since membranes from COS-7
cells, which express comparable amounts of receptors, do
not provide suitable substrates in this assay. Interestingly,
background phosphorylation in COS-7 cell membranes is
usually much higher. In addition, photoaffinity-labeling ex-
periments suggest that unlike receptors in Sf9 and 293 cells,j%-ARs expressed in COS-7 cells migrate as multiple diffuse
bands upon SDS/PAGE presumably due to heterogeneous
glycosylation (data not shown). This may further impair the
ability to concentrate the [32P]receptor species in a narrow
band within the gel.
Phosphorylation of G-protein-coupled receptori in the na-
tive plasma membrane environment provides a versatile ap-
proach to the study of these regulatory mechanisms that, to
our knowledge, has not previously been available. In addition,
from the data presented here, it appears that the membrane
assay more closely reflects the whole cell environment than
purified receptors in reconstituted phospholipid vesicles.
Thus, GRK2 phosphorylation of 2-AR was much faster than
that of reconstituted receptors, narrowing the gap in the
kinetics of receptor phosphorylation between in vivo and in
vitro studies (19, 30, 31). In. addition, the maximum stoichi-
ometry of P2-AR phosphorylation in membranes in the pres-
ence of agonist and B3y subunits is much closer to what is
routinely observed in whole-cell phosphorylation experiments
(3-4 mol of Pi per mol of receptor) as opposed to the higher
stoichiometry (7-10 mol of Pi per mol of receptor) often
demonstrated with reconstituted receptors (13, 17). The fac-
tors responsible for these differences are currently unknown.
We also demonstrate here, using the in vitro assay, that
marked specificity exists in the ability of various GRKs to
phosphorylate G-protein-coupled receptors. Whereas previ-
ous studies had indicated that specificity existed between the
ability of rhodopsin kinase and BARK to phosphorylate
rhodopsin and P2-AR (7), little or no difference was found in
the ability ofGRK2 and -3 to phosphorylate other receptors.
Here we clearly show that the a2-C2-AR receptor that is an
excellent substrate for GRK2 and -3 is an extremely poor
substrate for GRK5. These results demonstrate how the
availability of a direct biochemical approach to study G-pro-
tein-coupled receptor regulation has the potential to mark-
edly facilitate acquisition ofinformation concerning the spec-
ificity and mechanism of the GRKs.
We thank Dr. Hitoshi Kurose for providing the recombinant
cv2-C2-AR baculovirus construct, Dr. Richard Premont for purified
GRK5, Darrell Capel for purified fARK1 and ,ARK2, Drs. Pat
Casey and Jim Inglese for purified ,By subunits, and Grace Iron and
Lucie Bertrand for cell culture. We thank also Dr. Luc M6nard for
insightful suggestions and Donna Addison and Mary Holben for
typing the manuscript. This work was supported in part by National
Institutes of Health Grants HL 16037 to R.J.L. and NS19576 to
M.G.C. M.T. is a recipient of a Young Investigator Award from the
National Alliance for Research in Schizophrenia and Depression
(NARSAD).
1. Hausdorff, W. P., Caron, M. G. & Lefkowitz, R. J. (1990)
FASEB J. 4, 2881-2889.
2. Inglesej J., Freedman, N. J., Koch, W. J. & Lefkowitz, R. J.
(1993) J. Biol. Chem. 268, 23735-23779.
3. Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G. &
Lefkowitz, R. J. (1990) Science 248, 1547-1550.
4. Lorenz, W., Ingless, J., Palczewski, K., Onorato, J. J., Caron,
M. G. & Lefkowitz, R. J. (1991) Proc. Nati. Acad. Sci. USA
88, 8715-8719.
5. Benovic, J. L., DeBlasi, A., Stone, W. C., Caron, M. G. &
Lefkowitz, R. J. (1989) Science 246, 235-240.
6. Chuang, T. T., Sallese, M., Ambrosini, G., Parruti, G. &
DeBlasi, A. (1992) J. Biol. Chem. 267, 6886-6892.
7. Benovic, J. L., Onorato, J. J., Arriza, J. L., Stone, W. C.,
Lohse, M., Jenkins, N. A., Gilbert, D. J., Copland, N. G.,
Caron, M. G. & Lefkowitz, R. J. (1991) J. Biol. Chem. 266,
14939-14946.
8. Ambrose, C., James, M., Barnes, G., Lin, C., Bates, G.,
Altherr, M., Duyao, M., Groot, N., Church, D., Wasmuth,
J. J., Lehrach, H., Houseman, D., Buckler, A., Gusella, J. F.
& MacDonald, M. E. (1993) Hum. Mol. Genet. 1, 6697-6703.
9. Kunapuli, P. & Benovic, J. L. (1993) Proc. Nati. Acad. Sci.
USA 90, 5588-5592.
10. Premont, R. T., Walter, J. K., Inglese, J. & Lefkowitz, R. L.
(1994) J. Biol. Chem. 269, 6832-6841.
11. Benovic, J. L. & Gomez, J. (1993) J. Biol. Chem. 268, 19521-
19527.
12. Harribabu, B. & Snyderman, R. (1993) Proc. Nati. Acad. Sci.
USA 90, 9398-9402.
13. Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey,
P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, G. M.
& Lefkowitz, R. L. (1992) Science 257, 1264-1267.
14. Dolph, P. J., Ranganathan, R., Colley, N. J., Hardy, R. N.,
Socolich, M. & Zuker, C. S. (1993) Science 260, 1910-1916.
15. Boekhoff, I., Schleicher, S., Strotmann, J. & Breer, H. (1992)
Proc. Nati. Acad. Sci. USA 89, 11983-11987.
16. Dawson, T. M., Arriza, J. L., Jawarsky, D. E., Borisy, F. F.,
Attramadal, H., Lefkowitz, R. J. & Ronnett, G. V. (1993)
Science 259, 825-829.
17. Benovic, J. L., Mayor, F., Jr., Staniszewski, C., Lefkowitz,
R. J. & Caron, M. G. (1987) J. Biol. Chem. 262, 9026-9032.
18. Benovic, J. L., Regan, J. R., Matsui, H., Mayor, F., Cotec-
chia, S., Leeb-Lundberg, L. M. F., Caron, M. G. & Lefkow-
itz, R. J. (1987) J. Biol. Chem. 262, 17251-17253.
19. Kwatra, M. M., Benovic, J. L., Caron, M. G., Lefkowitz,
R. J. & Hose*, M. M. (1989) Biochemistry 28, 4543-4547.
20. Kwatra, M. M., Schwinn, D. A., Schreurs, J., Blank, J. L.,
Krause, J., Kim, C., Benovic, J. L., Caron, M. G. & Lefkow-
itz, R. J. (1993) J. Biol. Chem. 268, 9161-9164.
21. Ishii, K., Chen, J., Ishii, M., Koch, W. J., Freedman, N. J.,
Lefkowitz, R. J. & Coughlin, S. R. (1994) J. Biol. Chem. 269,
1125-1130.
22. Cullen, B. R. (1987) Methods Enzymol. 152, 684-704.
23. Samama, P., Cotecchia, S., Costa, T. & Lefkowitz, R. J. (1993)
J. Biol. Chem. 268, 4625-4636.
24. Kurose, H., Arriza, J. L. & Lefkowitz, R. J. (1993) Mol.
Pharmacol. 43, 444-450.
25. Lohse, M. J., Benovic, J. L., Caron, M. G. & Lefkowitz, R. J.
(1990) J. Biol. Chem. 265, 3202-3209.
26. Casey, P. J., Graziano, M. P. & Gilman, A. G. (1989) Bio-
chemistry 28, 611-616.
27. Benovic, J. L., Shorr, R. G., Caron, M. G. & Lefkowitz, R. J.
(1984) Biochemistry 23, 4510-4518.
28. Cerione, R. A., Strulovic, B., Benovic, J. L., Lefkowitz, R. J.
& Caron, M. G. (1983) Nature (London) 360, 684-686.
29. Johnston, R. F., Pickett, S. C. & Barker, D. L. (1990) Elec-
trophoresis 11, 355-360.
30. Roth, N. S., Campbell, P. T., Caron, M. G., Letkowitz, R. J.
& Lohse, M. J. (1991) Proc. Nati. Acad. Sci. USA 88, 6201-
6204.
31. Kwatra, M. M., Leung, E., Maan, A. C., McMahon, K. K.,
Ptasienski, J., Green, R. D. & Hosey, M. M. (1987) J. Biol.
Chem. 262, 16314-16321.
3636 Biochemistry: Pei et aL
